ASH Research Collaborative Data Hub

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
ASH Research Collaborative
Study ID
NCT05775224
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from basic, translational, clinical and population perspectives offer the possibility of improving the way that these diseases are treated, and the outcomes experienced by patients. A repository that aggregates and validates this data across institutions and other practice settings is needed in order to identify variation in care, new findings, and further research.

Key Dates

Start date
Apr 29, 2020
Status verified
Jun 2024
Primary completion
Apr 29, 2099
Completion
Apr 29, 2099

Study Design

Enrollment
100,000 participants (estimated)

Arms

  • Arm: Sickle Cell Disease
  • Arm: Multiple Myeloma

Primary Outcome Measure

Data Collection [ Time Frame: 50 year recruitment period (there will be continuous subgroup analyses through study completion) ]

Locations (1)

FacilityCityStateZIPSite coordinators
ASH Research CollaborativeWashington D.C.District of Columbia20036-

Find similar trials in Washington D.C., DC

By condition
Multiple myelomaSickle cell disease
By specialty
OncologyBlood cancer
By research site
ASH Research Collaborative· Washington D.C., DC

Related Studies